RB
Richmond Brothers Portfolio holdings
AUM
$153M
This Quarter Return
+16.66%
1 Year Return
+15.91%
3 Year Return
+117.95%
5 Year Return
–
10 Year Return
–
AUM
$59.3M
AUM Growth
+$59.3M
(-17%)
Cap. Flow
-$22.5M
Cap. Flow
% of AUM
-38.04%
Top 10 Holdings %
Top 10 Hldgs %
92.65%
Holding
22
New
1
Increased
1
Reduced
20
Closed
–
Top Buys
| 1 |
IRD
Opus Genetics, Inc. Common Stock
IRD
|
$43.3K |
| 2 |
ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
|
$30.1K |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
$8.31M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
$3.87M |
| 3 |
Apple
AAPL
|
$2.6M |
| 4 |
Guggenheim Strategic Opportunities Fund
GOF
|
$2.02M |
| 5 |
iShares Biotechnology ETF
IBB
|
$1.71M |
Sector Composition
| 1 | Technology | 17.56% |
| 2 | Healthcare | 14.16% |
| 3 | Financials | 11.56% |
| 4 | Communication Services | 1.66% |
| 5 | Consumer Discretionary | 1.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Invesco QQQ Trust
QQQ
$364B
| $19.9M | 33.56% |
61,969
-25,881
| -29% | -$8.31M |
|
|
2
Apple
AAPL
$3.45T
| $8.15M | 13.76% |
49,439
-15,775
| -24% | -$2.6M |
|
|
3
Berkshire Hathaway Class B
BRK.B
$1.09T
| $6.85M | 11.56% |
22,179
-12,532
| -36% | -$3.87M |
|
4
MiMedx Group
MDXG
$1.05B
| $5.98M | 10.1% |
1,755,127
-461,693
| -21% | -$1.57M |
|
|
5
Guggenheim Strategic Opportunities Fund
GOF
$2.62B
| $5.15M | 8.7% |
318,696
-124,886
| -28% | -$2.02M |
|
6
ARK Innovation ETF
ARKK
$7.45B
| $2.36M | 3.99% |
58,554
-11,371
| -16% | -$459K |
|
7
Microsoft
MSFT
$3.77T
| $2.25M | 3.8% |
7,811
-1,937
| -20% | -$558K |
|
|
8
iShares Biotechnology ETF
IBB
$5.6B
| $2.16M | 3.64% |
16,724
-13,261
| -44% | -$1.71M |
|
|
IRD
9
Opus Genetics, Inc. Common Stock
IRD
$73.1M
| $1.28M | 2.15% |
340,526
+11,556
| +4% | +$43.3K |
|
10
Rockwell Medical
RMTI
$58.9M
| $825K | 1.39% |
455,938
-111,435
| -20% | -$202K |
|
11
Nuveen AMT-Free Municipal Credit Income Fund
NVG
$2.53B
| $786K | 1.33% |
66,732
-38,144
| -36% | -$449K |
|
12
Air Industries Group
AIRI
$15.2M
| $514K | 0.87% |
135,019
-5,051
| -4% | -$19.2K |
|
13
McDonald's
MCD
$224B
| $455K | 0.77% |
1,629
-282
| -15% | -$78.8K |
|
14
Alphabet (Google) Class C
GOOG
$2.58T
| $408K | 0.69% |
3,920
-1,846
| -32% | -$192K |
|
15
Amazon
AMZN
$2.44T
| $401K | 0.68% |
3,886
-826
| -18% | -$85.3K |
|
16
iShares Core S&P 500 ETF
IVV
$662B
| $376K | 0.63% |
915
-159
| -15% | -$65.4K |
|
17
Verizon
VZ
$186B
| $361K | 0.61% |
9,288
-3,365
| -27% | -$131K |
|
18
Procter & Gamble
PG
$368B
| $278K | 0.47% |
1,867
-172
| -8% | -$25.6K |
|
19
Johnson & Johnson
JNJ
$427B
| $272K | 0.46% |
1,753
-228
| -12% | -$35.3K |
|
20
Invesco S&P 500 Low Volatility ETF
SPLV
$8B
| $259K | 0.44% |
4,143
-2,264
| -35% | -$141K |
|
21
AT&T
T
$209B
| $218K | 0.37% |
11,300
-4,595
| -29% | -$88.5K |
|
|
ONCT
22
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $30.1K | 0.05% |
+38,362
| New | +$30.1K |
|